Day 3 of Medica
Day 3 of the MEDICA Trade Fair. We're on booth J60.3, Hall 16 ready to welcome you to our booth and show exactly how Premium Cold Plasma is revolutionising the way patients with chronic wounds are being fully healed even if they have heavy biofilm presence.
Sitting at the forefront of the Cold Plasma market
There's a reason why we're the leaders of Cold Plasma.
Adtec Healthcare Ltd has been at the forefront of Cold Plasma by having the most experience on the market. We have invested years of gathering strong clinical evidence all the way from being the first company worldwide to introduce Cold Plasma on wounds in clinical trials many years ago to having our medical device widely adopted in hospitals across the UK and Europe.
The SteriPlas is the only Cold Plasma medical device with anti-biofilm efficacy by having dense, rich, microwave-driven Cold Plasma. No side effects have been reported with the use of our medical device.
To learn about the #mythbusting on Cold Plasma visit our webpage: https://adtechealthcare.com/cold-plasma-wound-treatment/
#MEDICA2023 #ABHI #ABHI2023 #Medicaldistributor #Investors
Day 2 of Medica
Our presentation today was met with much success.
The SteriPlas has proven antibacterial efficacy for the treatment of chronic wounds, surgical site infections and medical dermatology. If you would like to learn more, please visit our booth J60 in Hall 16 during the MEDICA-TradeFair.
Day 1 of Medica
Day 1 of the MEDICA Trade Fair was a success. Interacting with many distributors and clinicians with positive interest in our promising Premium Cold Plasma. We encourage you to visit our booth again today to see why the SteriPlas is revolutionising the global wound care market.
Don't forget to attend our presentation today from 11:55 - 12:15 at the ABHI stand. We will be presenting the strong clinical evidence of the SteriPlas Premium Cold Plasma used for wounds, Surgical Site Infections and medical dermatology in the UK Theatre in Hall 16, J48.
Adtec Healthcare to present at the Medica 2023 Trade Fair
Don't forget to attend our presentation during the MEDICA Trade Fair on Tuesday 16th November from 11:55 - 12:15. We will be presenting the strong clinical evidence of the SteriPlas Premium Cold Plasma used for chronic wounds, surgical site infections and medical dermatology in the UK Theatre in Hall 16, J48.
Visit us at booth J60.3, Medica 2023
Next week we’ll be exhibiting at the Medica Trade Fair 2023 exhibition with the ABHI and UK Healthcare Pavilion. You can find us at booth J60.3 in Hall 16. Be sure to stop by to see our SteriPlas Premium Cold Plasma medical device live in action and ready to demonstrate its strong clinical efficacy for wounds, surgical site infections and medical dermatology conditions.
Adtec Healthcare is also eager to meet with new medical distributors to continue to expand the reach of our Cold Plasma globally. If you are a distributor and willing to learn about the strong cost saving benefits and accelerated healing of chronic wounds with biofilm please be sure to pay us a visit.
Medica Trade Fair 2023
We are delighted to be joining The Association of British HealthTech Industries (ABHI) and UK Healthcare Pavilion at the Medica Trade Fair next week, showcasing the strengths of UK HealthTech alongside 40 of the UK’s leading industry players. Come visit us at booth J60.3, Hall 16 and discover the best of the UK.
Our Presentation video from the LSI Emerging Medtech Conference
Last month our CEO had presented the strong antibacterial benefits, clinical evidence and our business plan for our Premium Cold Plasma at the Life Science Intelligence (LSI) Emerging Medtech Conference.
After much positive interactions since the LSI which has led to promising meetings, we share with you that presentation : https://fb.watch/nWbLL1E_8d/
Adtec Microwave Argon Plasma has proven clinical efficacy in chronic infection management compared to standard care.
Adtec’s patented microwave argon plasma was designed specifically to create a denser safe plasma to manage infection with proven clinical efficacy over standard treatments. Our Plasma blend is effective at treating bacteria enclosed within biofilm and reaching hard to treat areas e.g. along drivelines. This clinical evidence has been presented at conferences and published in over 80 peer-reviewed publications.
The recent clinical evidence featured in Mr Thomas Schlöglhofer’s data illustrates the advantages of our SteriPlas medical device for deep LVAD infections. This showed Adtec Cold Plasma had 81% efficacy at wound management vs 47.1% efficacy with standard of care.
“Cold Atmospheric Plasma Therapy as an Effective Treatment of Left Ventricular Assist Device Driveline Infections” at the EACTS European Association for Cardio-Thoracic Surgery conference in Vienna (October 2023) presented by Mr Thomas Schlöglhofer, the Department of Cardiac Surgery, Medical University of Vienna.
Clinical Trials conducted using Adtec microwave argon plasma results include a 73.5% reduction in bacterial load with standard of care plus plasma treatment compared to a 50% reduction with standard of care alone. This represents a 47% increase in bacterial load reduction with SOC and plasma compared to SOC. All 24 patients received standard wound care to all wounds; 22 patients also received systemic antibiotics (92%).
Successful and Safe Use of 2 Min Cold Atmospheric Argon Plasma in Chronic Wounds: Results of A Randomized Controlled Trial. Isbary, G., et al British Journal of Dermatology, 2012. 167(2)
TFDA Approves SteriPlas in Taiwan
It is with great pleasure that we announce the SteriPlas Cold Plasma medical device is now an approved product in Taiwan, making it the first Cold Plasma medical device to be issued in the country. Adtec Healthcare Limited owes its thanks and praises to our exclusive distributor in Taiwan, SG Biomedical, whom without their skills in Regulatory and with the TFDA, none of this would have been possible.
The SteriPlas is already renowned in Taiwan for its strong clinical efficacy using premium and dense Cold Plasma and is set for distribution across the leading hospitals dealing with wound care. This is set to start within the coming months. If you are a health care professional in Taiwan that manages chronic wounds, we humbly request that you contact SG Biomedical who can guide you on the strong antibacterial benefits of the SteriPlas for diabetic foot ulcers, LVAD infections, sternal wounds and many more.
http://www.sghlds.com/index.php/tw/
